Alaven launches Bifera iron supplement
Atlanta Alaven Consumer Healthcare on Monday launched its Bifera iron supplement, in preparation for the ECRM Vitamin, Diet and Sports Nutrition conference being held here Jan. 20 through Jan. 23.
Unique to the iron supplement category, Bifera offers both heme (protein-based iron) and non-heme iron (plant-based iron). Unlike other iron supplements available over-the-counter, Bifera provides two types of iron in one small pill for maximum absorption with virtually no gastrointestinal side effects. “Bifera can be taken on an empty stomach, with other multi-vitamin supplements and, unlike other over-the-counter iron supplements, Bifera can be taken with acid reduction medications,” stated Autumn Akin, Bifera product manager.Bifera is similar to Alaven’s current prescription prenatal supplement PreferaOB, which contains both heme and non-heme iron. Bifera is recommended for adults already taking supplemental iron, women of childbearing age, pregnant women, people who are anemic, and men and women who simply need more iron in their diet and the energy it provides.According to Curt Behrens, president of P2B, a retail sales and marketing company, Bifera is a significant advance among iron supplements. “This new iron technology will help millions of consumers and energize a sleepy category for retailers,” said Behrens. “Bifera’s new entrance into the iron category will appeal to dieticians, repeat buyers and lapsed iron users who are looking for reduced side effects and enhanced energy, all of which encourages patient compliance and repeat customers.”
NPA criticizes remarks tying dietary supplements to tainted products
WASHINGTON The Natural Products Association on Thursday released a statement criticizing the erroneous link between legitimate dietary supplements and tainted products. “Increased scrutiny by professional sports leagues on steroid usage, which the Natural Products Association commends, has unfortunately also led to increased and unsubstantiated allegations that a ‘tainted’ or mislabeled dietary supplement is to blame when an athlete tests positive for a banned substance,” said David Seckman, NPA executive director and CEO.
“As the Dietary Supplement Health and Education Act of 1994 mandates, all ingredients must be listed on product labels and product claims must be substantiated. If this is not the case, the U.S. Food and Drug Administration—along with the Federal Trade Commission—have the authority under DSHEA to act promptly,” he said.
Seckman also noted that not all substances banned by professional sports organizations as performance enhancers are either bad or illegal. “Performance enhancers [that] are not necessarily dangerous or illegal … include caffeine, commonly used over-the-counter cold remedies and prescription medications,” he said. “Athletes have the right and responsibility to avoid their use. However, the consuming public who benefits from legitimate medications or dietary supplements – as well as a trip to the local coffee house – should not be denied their use if an athlete is unwilling or unable to follow the rules established by their sport.”
FDA hosts women’s health meeting Feb. 9
ROCKVILLE, Md. The Food and Drug Administration will be hosting a meeting on women’s health in Washington on Feb.9, according to a document slated to be published in the Federal Register on Monday.
The three-hour meeting is intended for directors of national organizations interested in discussing women’s health research and educational out reach.